Prevalence of QT Interval Prolongation in Patients Admitted to Cardiac Care Units and Frequency of Subsequent Administration of QT Interval-Prolonging Drugs: A Prospective, Observational Study in a Large Urban Academic Medical Center in the US

By Tisdale James E.   Wroblewski Heather A.  

Drug Safety, Vol. 35, Iss. 6, 2012-06 ,pp. : 459-470

Adis International

Access to resources Recommend Favorite

Development of cardiac safety translational tools for QT prolongation and torsade de pointes

By Valerio Luis G  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 7, 2013-07 ,pp. : 801-815

Informa Healthcare

Access to resources Recommend Favorite

Drugs, QT Interval Prolongation and ICH E14: The Need to Get it Right

By Rashmi R. Shah  

Drug Safety, Vol. 28, Iss. 2, 2005-01 ,pp. : 115-125

Adis International

Access to resources Recommend Favorite

Prolongation in QT interval is not predictive of Ca²⁺-dependent arrhythmias: implications for drug safety

By Pasquié Jean-Luc   Richard Sylvain  

Expert Opinion on Drug Safety, Vol. 8, Iss. 1, 2009-01 ,pp. : 57-72

Informa Healthcare

Access to resources Recommend Favorite

Statistical Characterization of QT Prolongation

By Schall Robert  

Journal of Biopharmaceutical Statistics, Vol. 20, Iss. 3, 2010-05 ,pp. : 543-562

Taylor & Francis Ltd

Access to resources Recommend Favorite